Finnrick - Ensuring a Safer and More Transparent Supply Chain
Wuhan Wansheng Biotechnology

Wuhan Wansheng Biotechnology
Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Wuhan Wansheng Biotechnology between 4 Aug 2025 and 21 Aug 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
Wuhan Wansheng Biotechnology
Retatrutide
Tested 6 Samples
Last test 21 Aug 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Wuhan Wansheng Biotechnology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.2MIN4.6MAX9.7

Last

21 Aug 2025

First

4 Aug 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
21 Aug 2025View7.510mg10.000mg99.70%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
11 Aug 2025View8.010mg9.580mg-4.2%99.95%(no batch ID)No Label / Silver Crimp / Clear Blue Cap Lab EPublic
4 Aug 2025View4.610mg11.170mg+11.7%99.24%(no batch ID)White Label / Copper Crimp / Clear CapLab DPublic
4 Aug 2025View9.720mg19.100mg-4.5%99.78%WWB-0830White Label / Silver Crimp / Violet Cap Lab EPublic
4 Aug 2025View5.920mg22.270mg+11.3%99.79%(no batch ID)No Label / Silver Crimp / Black CapLab APublic
4 Aug 2025View7.510mg10.260mg+2.6%99.68%(no batch ID)White Label / Silver Crimp / Green CapLab APublic